Status:
TERMINATED
Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Cervical Dystonia
Eligibility:
All Genders
18-70 years
Brief Summary
Cervical dystonia is the most common form of focal dystonia in adults (50-82%). It manifests itself by a abnormal attitude of the head, intermittent or permanent, due to involuntary contraction of the...
Eligibility Criteria
Inclusion
- Patients between the ages of 18 and 70
- Presenting with a diagnosed focal CD with predominantly rotational by a neurologist specialized in abnormal movements
- Receiving botulinum toxin injection at OIC level as part of his treatment
- Express consent to participate in the study
- Member of or beneficiary of a social security scheme
Exclusion
- Mobile DC (scrapie and/or myoclonic) that cannot be controlled the recording time by the CBCT system
- Having already benefited from an injection of BoNT as part of their DC in the last three months
- Inability to sit still
- Neurological condition other than DC (parkinsonian syndrome typical or atypical, others.)
- Severe neck pain
- Known or suspected trauma or pathology of the cervical spine, other than DC, having required treatment in the last 6 month
- Same old surgery of the cervical spine
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding women (a urine pregnancy test will be carried out in women under 50)
Key Trial Info
Start Date :
September 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2025
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05327985
Start Date
September 10 2024
End Date
July 8 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Fondation Adolphe de Rothschild
Paris, France, 75019